Merz's Novabel Suspended In EU, Pausing New Business Strategy
This article was originally published in The Gray Sheet
U.K authorities told health care professionals and aesthetic practitioners on August 12 not to use Merz Pharmaceuticals' dermal filler Novabel (alginate) because of a potential association with skin nodules and induration, particularly in the infra-orbital area, and to return all unused product to the company
You may also be interested in...
Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.